Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA polymerases involved in repair are a specialized group of enzymes responsible for maintaining genomic integrity by filling gaps and bypassing lesions during various DNA repair pathways [14, 15]. Unlike high-fidelity replicative polymerases such as DNA polymerase delta and epsilon, these repair polymerases—including members of the X-family (Pol Beta, Lambda, Mu) and Y-family (Pol Eta, Iota, Kappa)—often lack proofreading activity and can synthesize DNA across damaged templates, a process known as translesion synthesis [1, 3, 15]. In the context of oncology, these enzymes are critical therapeutic targets because they contribute to chemoresistance by repairing damage caused by platinum agents or ionizing radiation [1, 17, 20]. For instance, DNA polymerase theta (Pol Theta) has emerged as a prominent synthetic lethal target in homologous recombination-deficient cancers, such as those with BRCA1 or BRCA2 mutations, as it provides an alternative, error-prone repair pathway that these cells depend upon for survival [4, 9, 13]. Inhibiting these polymerases can sensitize tumor cells to conventional therapies or selectively induce cell death in specific genetic backgrounds, offering a strategy for precision medicine [8, 10, 16]. Furthermore, deficiencies in these enzymes are linked to hereditary conditions like xeroderma pigmentosum, highlighting their essential role in protecting against environmental genotoxins [3, 8].
Inhibition of DNA synthesis during repair, synthetic lethality in homologous recombination-deficient cells, and sensitization to DNA-damaging agents through the prevention of lesion bypass or gap filling.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA polymerases involved in repair.